APO Research
Talk to an analyst

APO RESEARCH · REPORT

Granulocyte Macrophage Colony Stimulating Factor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Granulocyte Macrophage Colony Stimulating Factor Industry Growth and Trends Forecast to 2032

19 December 2025103 pages

Choose your research edition.

Industry ResearchGranulocyte Macrophage Colony Stimulating Factor Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Granulocyte Macrophage Colony Stimulating Factor Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Granulocyte Macrophage Colony Stimulating Factor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granulocyte Macrophage Colony Stimulating Factor Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Granulocyte Macrophage Colony Stimulating Factor Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Granulocyte Macrophage Colony Stimulating Factor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Granulocyte Macrophage Colony Stimulating Factor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Granulocyte Macrophage Colony Stimulating Factor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Granulocyte Macrophage Colony Stimulating Factor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Granulocyte Macrophage Colony Stimulating Factor include Takeda Pharmaceutical Co Ltd, GlaxoSmithKline Plc, Amgen Inc, Sillajen Biotherapeutics, Morphotek Inc, Mologen AG, Humanigen Inc, Cold Genesys Inc and BriaCell Therapeutics Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Granulocyte Macrophage Colony Stimulating Factor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Granulocyte Macrophage Colony Stimulating Factor market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Granulocyte Macrophage Colony Stimulating Factor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Granulocyte Macrophage Colony Stimulating Factor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Granulocyte Macrophage Colony Stimulating Factor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Granulocyte Macrophage Colony Stimulating Factor Market by Company

Takeda Pharmaceutical Co Ltd

GlaxoSmithKline Plc

Amgen Inc

Sillajen Biotherapeutics

Morphotek Inc

Mologen AG

Humanigen Inc

Cold Genesys Inc

BriaCell Therapeutics Corp

Aduro BioTech Inc

Granulocyte Macrophage Colony Stimulating Factor Segment by Type

CG-0070

Lenzilumab

Gimsilumab

MGN-1601

GSK-3196165

Others

Granulocyte Macrophage Colony Stimulating Factor Segment by Application

Solid Tumor

Kidney Cancer

Lymphoma

Lung Disease

Others

Granulocyte Macrophage Colony Stimulating Factor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granulocyte Macrophage Colony Stimulating Factor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granulocyte Macrophage Colony Stimulating Factor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granulocyte Macrophage Colony Stimulating Factor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Granulocyte Macrophage Colony Stimulating Factor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Granulocyte Macrophage Colony Stimulating Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CG-0070 Table 2. Major Company of Lenzilumab Table 3. Major Company of Gimsilumab Table 4. Major Company of MGN-1601 Table 5. Major Company of GSK-3196165 Table 6. Major Company of Others Table 7. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 9. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Type (2021-2026) Table 10. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (US$ Million) Table 11. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Type (2021-2026) Table 12. Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2021-2026) & (US$/Unit) Table 13. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2027-2032) & (K Units) Table 14. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Type (2027-2032) Table 15. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2027-2032) & (US$ Million) Table 16. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Type (2027-2032) Table 17. Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2027-2032) & (US$/Unit) Table 18. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 19. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 21. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 25. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2021-2026) & (US$ Million) Table 28. Granulocyte Macrophage Colony Stimulating Factor Industry Trends Table 29. Granulocyte Macrophage Colony Stimulating Factor Industry Drivers Table 30. Granulocyte Macrophage Colony Stimulating Factor Industry Opportunities and Challenges Table 31. Granulocyte Macrophage Colony Stimulating Factor Industry Restraints Table 32. Global Granulocyte Macrophage Colony Stimulating Factor Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Company (2021-2026) Table 34. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Company (2021-2026) & (K Units) Table 35. Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Company (2021-2026) Table 36. Global Granulocyte Macrophage Colony Stimulating Factor Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Granulocyte Macrophage Colony Stimulating Factor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Granulocyte Macrophage Colony Stimulating Factor Major Company Production Sites and Headquarters Table 39. Global Granulocyte Macrophage Colony Stimulating Factor Company, Product Type & Application Table 40. Global Granulocyte Macrophage Colony Stimulating Factor Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Granulocyte Macrophage Colony Stimulating Factor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2021-2026) & (K Units) Table 45. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Region (2021-2026) Table 46. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2021-2026) & (US$ Million) Table 47. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Region (2021-2026) Table 48. Global Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2027-2032) & (K Units) Table 50. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Region (2027-2032) Table 51. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2027-2032) & (US$ Million) Table 52. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Region (2027-2032) Table 53. Global Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 56. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Application (2021-2026) Table 57. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (US$ Million) Table 58. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Application (2021-2026) Table 59. Global Granulocyte Macrophage Colony Stimulating Factor Price by Application (2021-2026) & (US$/Unit) Table 60. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2027-2032) & (K Units) Table 61. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Application (2027-2032) Table 62. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2027-2032) & (US$ Million) Table 63. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Application (2027-2032) Table 64. Global Granulocyte Macrophage Colony Stimulating Factor Price by Application (2027-2032) & (US$/Unit) Table 65. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 66. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 68. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 72. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2021-2026) & (US$ Million) Table 75. Takeda Pharmaceutical Co Ltd Company Information Table 76. Takeda Pharmaceutical Co Ltd Business Overview Table 77. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 79. Takeda Pharmaceutical Co Ltd Recent Development Table 80. GlaxoSmithKline Plc Company Information Table 81. GlaxoSmithKline Plc Business Overview Table 82. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 84. GlaxoSmithKline Plc Recent Development Table 85. Amgen Inc Company Information Table 86. Amgen Inc Business Overview Table 87. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 89. Amgen Inc Recent Development Table 90. Sillajen Biotherapeutics Company Information Table 91. Sillajen Biotherapeutics Business Overview Table 92. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 94. Sillajen Biotherapeutics Recent Development Table 95. Morphotek Inc Company Information Table 96. Morphotek Inc Business Overview Table 97. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 99. Morphotek Inc Recent Development Table 100. Mologen AG Company Information Table 101. Mologen AG Business Overview Table 102. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 104. Mologen AG Recent Development Table 105. Humanigen Inc Company Information Table 106. Humanigen Inc Business Overview Table 107. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 109. Humanigen Inc Recent Development Table 110. Cold Genesys Inc Company Information Table 111. Cold Genesys Inc Business Overview Table 112. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 114. Cold Genesys Inc Recent Development Table 115. BriaCell Therapeutics Corp Company Information Table 116. BriaCell Therapeutics Corp Business Overview Table 117. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 119. BriaCell Therapeutics Corp Recent Development Table 120. Aduro BioTech Inc Company Information Table 121. Aduro BioTech Inc Business Overview Table 122. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio Table 124. Aduro BioTech Inc Recent Development Table 125. North America Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Units) Table 127. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2021-2026) Table 128. North America Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2027-2032) & (K Units) Table 129. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Country (2027-2032) Table 130. North America Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. North America Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (2021-2026) & (US$ Million) Table 132. North America Granulocyte Macrophage Colony Stimulating Factor Market Share by Country (2021-2026) Table 133. North America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. North America Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Country (2027-2032) Table 135. Europe Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Units) Table 137. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2021-2026) Table 138. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2027-2032) & (K Units) Table 139. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Country (2027-2032) Table 140. Europe Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Europe Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (2021-2026) & (US$ Million) Table 142. Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by Country (2021-2026) Table 143. Europe Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Europe Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Units) Table 147. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2021-2026) Table 148. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2027-2032) & (K Units) Table 149. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (2021-2026) & (US$ Million) Table 152. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Share by Country (2021-2026) Table 153. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Country (2027-2032) Table 155. Latin America Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Units) Table 157. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2021-2026) Table 158. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2027-2032) & (K Units) Table 159. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Country (2027-2032) Table 160. Latin America Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Latin America Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (2021-2026) & (US$ Million) Table 162. Latin America Granulocyte Macrophage Colony Stimulating Factor Market Share by Country (2021-2026) Table 163. Latin America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Latin America Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026) & (K Units) Table 167. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2021-2026) Table 168. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2027-2032) & (K Units) Table 169. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (2021-2026) & (US$ Million) Table 172. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Share by Country (2021-2026) Table 173. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Share Forecast by Country (2027-2032) Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Granulocyte Macrophage Colony Stimulating Factor Distributors List Table 178. Granulocyte Macrophage Colony Stimulating Factor Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Granulocyte Macrophage Colony Stimulating Factor Image Figure 2. Global Granulocyte Macrophage Colony Stimulating Factor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Granulocyte Macrophage Colony Stimulating Factor Market Size (2021-2032) & (US$ Million) Figure 4. Global Granulocyte Macrophage Colony Stimulating Factor Sales (2021-2032) & (K Units) Figure 5. CG-0070 Image Figure 6. Global CG-0070 Sales YoY Growth (2021-2032) & (K Units) Figure 7. Lenzilumab Image Figure 8. Global Lenzilumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. Gimsilumab Image Figure 10. Global Gimsilumab Sales YoY Growth (2021-2032) & (K Units) Figure 11. MGN-1601 Image Figure 12. Global MGN-1601 Sales YoY Growth (2021-2032) & (K Units) Figure 13. GSK-3196165 Image Figure 14. Global GSK-3196165 Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Type 2025 VS 2032 Figure 19. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Type in 2025 Figure 20. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Type in 2025 Figure 21. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Type in 2025 Figure 22. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Type in 2025 Figure 25. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Granulocyte Macrophage Colony Stimulating Factor Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Solid Tumor Image Figure 32. Global Solid Tumor Sales YoY Growth (2021-2032) & (K Units) Figure 33. Kidney Cancer Image Figure 34. Global Kidney Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 35. Lymphoma Image Figure 36. Global Lymphoma Sales YoY Growth (2021-2032) & (K Units) Figure 37. Lung Disease Image Figure 38. Global Lung Disease Sales YoY Growth (2021-2032) & (K Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 41. Global Granulocyte Macrophage Colony Stimulating Factor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application 2025 VS 2032 Figure 43. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Application in 2025 Figure 44. North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Application in 2025 Figure 45. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Application in 2025 Figure 46. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Application in 2025 Figure 49. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share in Value by Application in 2025 Figure 53. North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. North America Granulocyte Macrophage Colony Stimulating Factor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Granulocyte Macrophage Colony Stimulating Factor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Granulocyte Macrophage Colony Stimulating Factor Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Granulocyte Macrophage Colony Stimulating Factor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Latin America Granulocyte Macrophage Colony Stimulating Factor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Granulocyte Macrophage Colony Stimulating Factor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Granulocyte Macrophage Colony Stimulating Factor Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 70. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Granulocyte Macrophage Colony Stimulating Factor Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Granulocyte Macrophage Colony Stimulating Factor Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • CG-0070
  • Lenzilumab
  • Gimsilumab
  • MGN-1601
  • GSK-3196165
  • Others
Applications
  • Solid Tumor
  • Kidney Cancer
  • Lymphoma
  • Lung Disease
  • Others
Companies covered
  • Takeda Pharmaceutical Co Ltd
  • GlaxoSmithKline Plc
  • Amgen Inc
  • Sillajen Biotherapeutics
  • Morphotek Inc
  • Mologen AG
  • Humanigen Inc
  • Cold Genesys Inc
  • BriaCell Therapeutics Corp
  • Aduro BioTech Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Granulocyte Macrophage Colony Stimulating Factor Market by Type
  6. 1.3.1 CG-0070
  7. 1.3.2 Lenzilumab
  8. 1.3.3 Gimsilumab
  9. 1.3.4 MGN-1601
  10. 1.3.5 GSK-3196165
  11. 1.3.6 Others
  12. 1.4 Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Type
  13. 1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Granulocyte Macrophage Colony Stimulating Factor Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Granulocyte Macrophage Colony Stimulating Factor Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Granulocyte Macrophage Colony Stimulating Factor Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Granulocyte Macrophage Colony Stimulating Factor Industry Trends
  2. 2.2 Granulocyte Macrophage Colony Stimulating Factor Industry Drivers
  3. 2.3 Granulocyte Macrophage Colony Stimulating Factor Industry Opportunities and Challenges
  4. 2.4 Granulocyte Macrophage Colony Stimulating Factor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Granulocyte Macrophage Colony Stimulating Factor Revenue (2021-2026)
  2. 3.2 Global Top Players by Granulocyte Macrophage Colony Stimulating Factor Sales (2021-2026)
  3. 3.3 Global Top Players by Granulocyte Macrophage Colony Stimulating Factor Price (2021-2026)
  4. 3.4 Global Granulocyte Macrophage Colony Stimulating Factor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Granulocyte Macrophage Colony Stimulating Factor Major Company Production Sites & Headquarters
  6. 3.6 Global Granulocyte Macrophage Colony Stimulating Factor Company, Product Type & Application
  7. 3.7 Global Granulocyte Macrophage Colony Stimulating Factor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Granulocyte Macrophage Colony Stimulating Factor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Granulocyte Macrophage Colony Stimulating Factor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Granulocyte Macrophage Colony Stimulating Factor Tier 1, Tier 2, and Tier 3
4 Granulocyte Macrophage Colony Stimulating Factor Regional Status and Outlook
  1. 4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Granulocyte Macrophage Colony Stimulating Factor Historic Market Size by Region
  3. 4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Granulocyte Macrophage Colony Stimulating Factor Forecasted Market Size by Region
  7. 4.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Granulocyte Macrophage Colony Stimulating Factor by Application
  1. 5.1 Granulocyte Macrophage Colony Stimulating Factor Market by Application
  2. 5.1.1 Solid Tumor
  3. 5.1.2 Kidney Cancer
  4. 5.1.3 Lymphoma
  5. 5.1.4 Lung Disease
  6. 5.1.5 Others
  7. 5.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Application
  8. 5.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Granulocyte Macrophage Colony Stimulating Factor Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Granulocyte Macrophage Colony Stimulating Factor Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Co Ltd
  2. 6.1.1 Takeda Pharmaceutical Co Ltd Company Information
  3. 6.1.2 Takeda Pharmaceutical Co Ltd Business Overview
  4. 6.1.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Co Ltd Recent Developments
  7. 6.2 GlaxoSmithKline Plc
  8. 6.2.1 GlaxoSmithKline Plc Company Information
  9. 6.2.2 GlaxoSmithKline Plc Business Overview
  10. 6.2.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  12. 6.2.5 GlaxoSmithKline Plc Recent Developments
  13. 6.3 Amgen Inc
  14. 6.3.1 Amgen Inc Company Information
  15. 6.3.2 Amgen Inc Business Overview
  16. 6.3.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  18. 6.3.5 Amgen Inc Recent Developments
  19. 6.4 Sillajen Biotherapeutics
  20. 6.4.1 Sillajen Biotherapeutics Company Information
  21. 6.4.2 Sillajen Biotherapeutics Business Overview
  22. 6.4.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  24. 6.4.5 Sillajen Biotherapeutics Recent Developments
  25. 6.5 Morphotek Inc
  26. 6.5.1 Morphotek Inc Company Information
  27. 6.5.2 Morphotek Inc Business Overview
  28. 6.5.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  30. 6.5.5 Morphotek Inc Recent Developments
  31. 6.6 Mologen AG
  32. 6.6.1 Mologen AG Company Information
  33. 6.6.2 Mologen AG Business Overview
  34. 6.6.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  36. 6.6.5 Mologen AG Recent Developments
  37. 6.7 Humanigen Inc
  38. 6.7.1 Humanigen Inc Company Information
  39. 6.7.2 Humanigen Inc Business Overview
  40. 6.7.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  42. 6.7.5 Humanigen Inc Recent Developments
  43. 6.8 Cold Genesys Inc
  44. 6.8.1 Cold Genesys Inc Company Information
  45. 6.8.2 Cold Genesys Inc Business Overview
  46. 6.8.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  48. 6.8.5 Cold Genesys Inc Recent Developments
  49. 6.9 BriaCell Therapeutics Corp
  50. 6.9.1 BriaCell Therapeutics Corp Company Information
  51. 6.9.2 BriaCell Therapeutics Corp Business Overview
  52. 6.9.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  54. 6.9.5 BriaCell Therapeutics Corp Recent Developments
  55. 6.10 Aduro BioTech Inc
  56. 6.10.1 Aduro BioTech Inc Company Information
  57. 6.10.2 Aduro BioTech Inc Business Overview
  58. 6.10.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Portfolio
  60. 6.10.5 Aduro BioTech Inc Recent Developments
7 North America by Country
  1. 7.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country
  2. 7.1.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026)
  4. 7.1.3 North America Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
  6. 7.2.1 North America Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (2021-2026)
  8. 7.2.3 North America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country
  2. 8.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026)
  4. 8.1.3 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
  6. 8.2.1 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Country
  2. 9.1.1 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
  6. 9.2.1 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Granulocyte Macrophage Colony Stimulating Factor Sales by Country
  2. 10.1.1 South America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026)
  4. 10.1.3 South America Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
  6. 10.2.1 South America Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (2021-2026)
  8. 10.2.3 South America Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country
  2. 11.1.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size by Country
  6. 11.2.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Granulocyte Macrophage Colony Stimulating Factor Value Chain Analysis
  2. 12.1.1 Granulocyte Macrophage Colony Stimulating Factor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Granulocyte Macrophage Colony Stimulating Factor Production Mode & Process
  7. 12.2 Granulocyte Macrophage Colony Stimulating Factor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Granulocyte Macrophage Colony Stimulating Factor Distributors
  10. 12.2.3 Granulocyte Macrophage Colony Stimulating Factor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst